ClearLight Diagnostics has appointed Laurie Goodman as CSO. In this role, she will serve as the company's principal scientific officer and will be responsible for the design and execution of ClearLight scientific development programs. Goodman has served as a consultant to ClearLight since August 2015. Before joining ClearLight, she served as senior director of medical affairs at Biodesix. She has also held positions of increasing responsibility at Affymetrix, Monogram Biosciences, and Lynx Therapeutics.